Skip to content

Free cash flow at other companies

Abbott logo
AbbottABT
$916M-1.8%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$546M
TFX
TeleflexTFX
$27.87M+676%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.47B-56.6%
Stryker logo
StrykerSYK
$415M+227%
Boston Scientific logo
Boston ScientificBSX
$171M-51.7%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%

Valuation

See full
Market cap$4.01B-34.1%
Enterprise value$4.34B-33.3%
P/E28.8×-21.0×
P/S2.6×-1.8×

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Calculated from Merit Medical Systems’s reported figures.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's free cash flow?
Merit Medical Systems (MMSI) reported free cash flow of $24.67M in Q1 2026.
How has Merit Medical Systems's free cash flow changed year-over-year?
Merit Medical Systems's free cash flow increased by 26.5% year-over-year, from $19.51M to $24.67M.
What is the long-term trend for Merit Medical Systems's free cash flow?
Over 4 years (2021 to 2025), Merit Medical Systems's free cash flow has grown at a 16.0% compound annual growth rate (CAGR), from $119.29M to $215.66M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.